Diamox, Acetazolamide Newswire

Diamox, Acetazolamide Newswire

Comprehensive Real-Time News Feed for Diamox, Acetazolamide (generic).

Results 1 - 20 of 28 in Diamox, Acetazolamide (generic)

  1. Existing drug may help to treat aggressive brain cancerRead the original story w/Photo

    Jul 11, 2018 | Medical News Today

    Healthline Media, Inc. would like to process and share personal data and data about your use of our site with our third party partners using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent. Healthline Media, Inc. is based in and operates this site from the United States.

    Comment?

  2. Altitude Sickness Drug Appears to Slow Progression of GlioblastomaRead the original story w/Photo

    Jul 10, 2018 | Health News Digest

    A drug used to treat altitude sickness - as well as glaucoma, epilepsy, heart failure and seizures - may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma, according to a study published July 4, 2018, in the journal The drug, acetazolamide, sold under the trade name Diamox, is "cheap to make, easy to take and has limited side effects," said study director Bahktiar Yamini, MD, a professor of neurosurgery at the University of Chicago Medicine. "I take it myself, whenever I go to the Rocky Mountains," he said, "two pills a day."

    Comment?

  3. Altitude sickness drug may help brain tumour patientsRead the original story

    Jul 10, 2018 | Newkerala.com

    New York, July 10 : A medication used to treat altitude sickness, glaucoma, epilepsy, heart failure and seizures may also help people suffering from fast-growing brain tumor known as glioblastoma live longer, according to a study. The researchers found that most glioblastoma patients with high levels of a protein called BCL-3 were unresponsive to the beneficial effects of temozolomide -- a frequently used chemotherapy for the disease.

    Comment?

  4. Altitude sickness drug may offer significant gains for patients with glioblastomaRead the original story w/Photo

    Jul 10, 2018 | Medical News

    A drug used to treat altitude sickness -- as well as glaucoma, epilepsy, heart failure and seizures -- may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma, according to a study published July 4, 2018, in the journal Science Translational Medicine . The drug, acetazolamide, sold under the trade name Diamox, is "cheap to make, easy to take and has limited side effects," said study director Bahktiar Yamini, MD, a professor of neurosurgery at the University of Chicago Medicine.

    Comment?

  5. From EpiPens to antibiotics, report finds Canada's drug shortages could be getting worseRead the original story w/Photo

    Jun 13, 2018 | CBC News

    Some Canadian patients have struggled to find medicine in recent years, and medical experts say the shortages have no easy solution. A new report probing Canada's struggle to keep pharmacy shelves stocked has turned up a number of possible causes, and the authors say that without swift action, the problem will only get worse.

    Comment?

  6. From EpiPens to antibiotics, report finds Canada's drug shortages could be getting worseRead the original story w/Photo

    Jun 14, 2018 | CBC News

    Some Canadian patients have struggled to find medicine in recent years, and medical experts say the shortages have no easy solution. A new report probing Canada's struggle to keep pharmacy shelves stocked has turned up a number of possible causes, and the authors say that without swift action, the problem will only get worse.

    Comment?

  7. Idiopathic basal ganglia calcification associated with cerebral micro-infarcts: a case reportRead the original story w/Photo

    Apr 16, 2018 | BioMed Central

    Idiopathic basal ganglia calcification is a rare neurodegenerative disorder characterized by symmetric intracranial calcium deposition. We report a patient with IBGC associated with cerebral infarction due to impairment of cerebrovascular reactivity based on single-photon emission computed tomography with acetazolamide challenge.

    Comment?

  8. Pseudotumor Cerebri Market 2018: Increasing Manufacturing Industry,...Read the original story w/Photo

    Apr 9, 2018 | SBWire

    Global Pseudotumor Cerebri Market is expected to grow at a CAGR of 6.2% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

    Comment?

  9. Critical Survey: LannettRead the original story w/Photo

    Feb 19, 2018 | IntersportsWire

    Lannett and Eyegate Pharmaceuticals are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Lannett presently has a consensus price target of $20.80, suggesting a potential upside of 21.99%.

    Comment?

  10. Lannett (LCI) & Eyegate Pharmaceuticals (EYEG) Head to Head ContrastRead the original story w/Photo

    Feb 17, 2018 | Daily Political

    Lannett and Eyegate Pharmaceuticals are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Lannett presently has a consensus price target of $20.80, suggesting a potential upside of 21.99%.

    Comment?

  11. Japanese short-track speedskater becomes first doping case of...Read the original story w/Photo

    Feb 13, 2018 | The Spokesman-Review

    Kei Saito, a reserve on Japan's short-track speedskating team, is the first athlete to test positive for a banned substance at the Pyeongchang Olympics, the Court of Arbitration for Sport announced Tuesday. Provisionally suspended, Saito has agreed to leave the Olympic Village and will not participate in this year's games, the court said.

    Comment?

  12. Japanese short-track skater fails doping testRead the original story w/Photo

    Feb 13, 2018 | English Dong-A

    Japanese short-track skater fails doping test. February. 14, 2018 07:52. by Seong-Taek Jeong, Won-Jae Jang neone@donga.com,peacechaos@donga.com.

    Comment?

  13. Sport24.co.za | Japanese vows to clear name in first Olympics drug caseRead the original story w/Photo

    Feb 13, 2018 | News24

    Japanese short-track speed skater Kei Saito vowed to clear his name on Tuesday after testing positive for a banned substance in the first doping case to hit the Pyeongchang Olympics . The 21-year-old is the first Japanese to test positive at a Winter Olympics and he was immediately thrown out of the Games on Monday.

    Comment?

  14. Japanese Skater Banned From Olympics For Alleged DopingRead the original story w/Photo

    Feb 12, 2018 | WLEX-TV Lexington

    The Winter Olympic Games lost its first athlete to a doping suspension Tuesday after Japanese short track speedskater Kei Saito was found to have tested positive for a chemical used to mask the presence of banned drugs, the Court for Arbitration for Sport said. Saito, 21, who had been scheduled to take part Wednesday in heats for the men's 5,000-meter relay event, voluntarily accepted a provisional suspension and was ordered to leave the Olympic village in PyeongChang, South Korea, the international sports court said.

    Comment?

  15. Everything you need to know about papilledemaRead the original story w/Photo

    Feb 9, 2018 | Medical News Today

    Papilledema is a serious medical condition where the optic nerve at the back of the eye becomes swollen. Symptoms can include visual disturbances, headaches, and nausea.

    Comment?

  16. Financial Contrast: LannettRead the original story w/Photo

    Feb 1, 2018 | IntersportsWire

    Lannett and Eyegate Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations. Lannett has higher revenue and earnings than Eyegate Pharmaceuticals.

    Comment?

  17. Global Cystoid Macular Edema Market Made Impressive Gains by 2025Read the original story w/Photo

    Jan 17, 2018 | SBWire

    Cystoid macular edema also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema.

    Comment?

  18. Altitude Sickness Market Key Growth Factors and Forecast Up to 2025Read the original story w/Photo

    Jan 17, 2018 | SBWire

    Altitude sickness is also known as acute mountain sickness and is caused due to low levels of oxygen at very high altitudes owing to acute exposure to low partial oxygen pressure. Such a kind of sickness is known to occur above 2,500 meters.

    Comment?

  19. SLT Today: An Effective Alternative to DropsRead the original story w/Photo

    Dec 16, 2017 | Review of Ophthalmology

    In the past few decades ophthalmologists have been gradually using laser trabeculoplasty earlier and earlier in their glaucoma treatment protocols. When I first started my training, it was common practice to use every medication possible - sometimes even oral medications like acetazolamide - before resorting to laser trabeculoplasty.

    Comment?

  20. Why is my tongue tingling?Read the original story w/Photo

    Nov 28, 2017 | Medical News Today

    The medical name for a pins and needles sensation is parasthesia. It can affect all parts of the body, including the tongue.

    Comment?